Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADGM |
---|---|---|
09:32 ET | 259 | 2.3 |
09:35 ET | 1180 | 2.14 |
09:57 ET | 370 | 2.21 |
10:00 ET | 433 | 2.39 |
10:15 ET | 1626 | 2.21 |
10:18 ET | 995 | 2.23 |
10:24 ET | 1750 | 2.3873 |
10:31 ET | 800 | 2.391 |
10:33 ET | 1450 | 2.22 |
10:38 ET | 2080 | 2.2183 |
10:40 ET | 586 | 2.18 |
10:47 ET | 700 | 2.1871 |
10:49 ET | 800 | 2.2155 |
10:58 ET | 3305 | 2.2773 |
11:00 ET | 300 | 2.2859 |
11:02 ET | 100 | 2.3 |
11:05 ET | 100 | 2.3 |
11:20 ET | 1058 | 2.25 |
11:23 ET | 100 | 2.23 |
11:25 ET | 100 | 2.22 |
11:41 ET | 246 | 2.25 |
11:50 ET | 120 | 2.255 |
11:52 ET | 190 | 2.2388 |
12:01 ET | 100 | 2.28 |
12:10 ET | 1000 | 2.28 |
12:14 ET | 541 | 2.28 |
12:26 ET | 100 | 2.31 |
12:35 ET | 100 | 2.31 |
12:37 ET | 100 | 2.29 |
01:02 ET | 1000 | 2.3136 |
01:29 ET | 1000 | 2.35 |
02:00 ET | 100 | 2.3 |
02:20 ET | 4512 | 2.22 |
02:52 ET | 5000 | 2.3499 |
02:56 ET | 5000 | 2.2901 |
03:03 ET | 100 | 2.29 |
03:44 ET | 3547 | 2.35 |
03:46 ET | 1908 | 2.4 |
03:48 ET | 3170 | 2.44 |
03:51 ET | 100 | 2.44 |
03:53 ET | 2246 | 2.45 |
04:00 ET | 584 | 2.4342 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adagio Medical Holdings Inc | 30.5M | -13.1x | --- |
BioSig Technologies Inc | 33.3M | -1.4x | --- |
Know Labs Inc | 25.9M | -1.2x | --- |
Inspira Technologies Oxy BHN Ltd | 24.9M | -1.4x | --- |
Vivos Inc | 37.0M | -11.2x | --- |
Movano Inc | 21.0M | -0.7x | --- |
Adagio Medical Holdings, Inc. is a medical device company developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. A standalone PFA console connected to a cryoablation console for PFCA treatment synchronization is used in conjunction with Cryopulse catheter. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for treatment of the ventricular arrhythmia. Its product offerings consist largely of the single use ablation catheters and consoles.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 13.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.14 |
EPS | $-0.19 |
Book Value | $3.24 |
P/E Ratio | -13.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.